Show simple item record

dc.contributor.authorWatkins, E
dc.contributor.authorNewbold, A
dc.contributor.authorTester-Jones, M
dc.contributor.authorCollins, LM
dc.contributor.authorMostazir, M
dc.date.accessioned2023-11-16T12:58:51Z
dc.date.issued2023-06-28
dc.date.updated2023-11-16T11:22:33Z
dc.description.abstractIMPORTANCE: There is limited understanding of how complex evidence-based psychological interventions such as cognitive behavioral therapy (CBT) for depression work. Identifying active ingredients may help to make therapy more potent, brief, and scalable. OBJECTIVE: To test the individual main effects and interactions of 7 treatment components within internet-delivered CBT for depression to investigate its active ingredients. DESIGN, SETTING, AND PARTICIPANTS: This randomized optimization trial using a 32-condition, balanced, fractional factorial optimization experiment (IMPROVE-2) recruited adults with depression (Patient Health Questionnaire-9 [PHQ-9] score ≥10) from internet advertising and the UK National Health Service Improving Access to Psychological Therapies service. Participants were randomized from July 7, 2015, to March 29, 2017, with follow-up for 6 months after treatment until December 29, 2017. Data were analyzed from July 2018 to April 2023. INTERVENTIONS: Participants were randomized with equal probability to 7 experimental factors within the internet CBT platform, each reflecting the presence vs absence of specific treatment components (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, and self-compassion training). MAIN OUTCOMES AND MEASURES: The primary outcome was depression symptoms (PHQ-9 score). Secondary outcomes include anxiety symptoms and work, home, and social functioning. RESULTS: Among 767 participants (mean age [SD] age, 38.5 [11.62] years; range, 18-76 years; 635 women [82.8%]), 506 (66%) completed the 6-month posttreatment follow-up. On average, participants receiving internet-delivered CBT had reduced depression (pre-to-posttreatment difference in PHQ-9 score, -7.79 [90% CI, -8.21 to -7.37]; 6-month follow-up difference in PHQ-9 score, -8.63 [90% CI, -9.04 to -8.22]). A baseline score-adjusted analysis of covariance model using effect-coded intervention variables (-1 or +1) found no main effect on depression symptoms for the presence vs absence of activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, or self-compassion training (posttreatment: largest difference in PHQ-9 score [functional analysis], -0.09 [90% CI, -0.56 to 0.39]; 6-month follow-up: largest difference in PHQ-9 score [relaxation], -0.18 [90% CI, -0.61 to 0.25]). Only absorption training had a significant main effect on depressive symptoms at 6-month follow-up (posttreatment difference in PHQ-9 score, 0.21 [90% CI, -0.27 to 0.68]; 6-month follow-up difference in PHQ-9 score, -0.54, [90% CI, -0.97 to -0.11]). CONCLUSIONS AND RELEVANCE: In this randomized optimization trial, all components of internet-delivered CBT except absorption training did not significantly reduce depression symptoms relative to their absence despite an overall average reduction in symptoms. The findings suggest that treatment benefit from internet-delivered CBT probably accrues from spontaneous remission, factors common to all CBT components (eg, structure, making active plans), and nonspecific therapy factors (eg, positive expectancy), with the possible exception of absorption focused on enhancing direct contact with positive reinforcers. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN24117387.en_GB
dc.description.sponsorshipCornwall Partnership NHS Foundation Trusten_GB
dc.description.sponsorshipSouth West Academic Health Science Networken_GB
dc.format.extent942-951
dc.format.mediumPrint
dc.identifier.citationVol. 80(9), pp. 942-951en_GB
dc.identifier.doihttps://doi.org/10.1001/jamapsychiatry.2023.1937
dc.identifier.urihttp://hdl.handle.net/10871/134559
dc.identifierORCID: 0000-0002-2432-5577 (Watkins, Edward)
dc.identifierORCID: 0000-0002-8657-515X (Mostazir, Mohammod)
dc.identifierScopusID: 55173782900 (Mostazir, Mohammod)
dc.language.isoenen_GB
dc.publisherAmerican Medical Association (AMA)en_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37378962en_GB
dc.rights© 2023 American Medical Associationen_GB
dc.titleInvestigation of active ingredients within internet cognitive-behavioral therapy for depression: a randomized optimization trialen_GB
dc.typeArticleen_GB
dc.date.available2023-11-16T12:58:51Z
dc.identifier.issn2168-622X
exeter.place-of-publicationUnited States
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Medical Association via the DOI in this recorden_GB
dc.identifier.eissn2168-6238
dc.identifier.journalJAMA Psychiatryen_GB
dc.relation.ispartofJAMA Psychiatry, 80(9)
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2023-04-22
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2023-06-28
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-11-16T12:56:43Z
refterms.versionFCDAM
refterms.dateFOA2023-11-16T12:58:56Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record